Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Suzette Delaloge"'
Breast cancer survivors’ opinion on personalizing endocrine therapy and developing informative tools
Autor:
Elie Rassy, Chiara Benvenuti, Sarra Akla, Antonio Di Meglio, Elise Martin, Julie Havas, André Rieutord, David Combarel, Léonor Fasse, Florian Scotté, Laure Guéroult Accolas, Guillemette Jacob, Anne Bergougnoux, Suzette Delaloge, Ines Vaz-Luis, Barbara Pistilli
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-6 (2024)
Abstract Understanding breast cancer survivors’ perspectives is critical to personalizing endocrine therapy (ET) in the adjuvant setting. A nationwide survey among breast cancer survivors was proposed in France, in collaboration with patient advoca
Externí odkaz:
https://doaj.org/article/d1fa8614642446248123b29cc4747664
Autor:
Vincent Carbonnier, Julie Le Naour, Thomas Bachelot, Erika Vacchelli, Fabrice André, Suzette Delaloge, Guido Kroemer
Publikováno v:
OncoImmunology, Vol 12, Iss 1 (2023)
ABSTRACTFormyl peptide receptor-1 (FPR1) is a pathogen recognition receptor involved in the detection of bacteria, in the control of inflammation, as well as in cancer immunosurveillance. A single nucleotide polymorphism in FPR1, rs867228, provokes a
Externí odkaz:
https://doaj.org/article/6cf335f1023b4cb78f735e7196aa4361
Autor:
Felicia Fei-Lei Chung, Sandra González Maldonado, Amelie Nemc, Liacine Bouaoun, Vincent Cahais, Cyrille Cuenin, Aurelie Salle, Theron Johnson, Bekir Ergüner, Marina Laplana, Paul Datlinger, Jana Jeschke, Elisabete Weiderpass, Vessela Kristensen, Suzette Delaloge, François Fuks, Angela Risch, Akram Ghantous, Christoph Plass, Christoph Bock, Rudolf Kaaks, Zdenko Herceg
Publikováno v:
Clinical Epigenetics, Vol 15, Iss 1, Pp 1-10 (2023)
Abstract Background Epigenetic alterations are a near-universal feature of human malignancy and have been detected in malignant cells as well as in easily accessible specimens such as blood and urine. These findings offer promising applications in ca
Externí odkaz:
https://doaj.org/article/f3d701c524644d55890c75bac50f8463
Autor:
Coralie Courtinard, Sophie Gourgou, William Jacot, Matthieu Carton, Olivier Guérin, Laure Vacher, Aurélie Bertaut, Marie-Cécile Le Deley, David Pérol, Patricia Marino, Christelle Levy, Lionel Uwer, Geneviève Perrocheau, Renaud Schiappa, Florence Bachelot, Damien Parent, Mathias Breton, Thierry Petit, Thomas Filleron, Agnès Loeb, Simone Mathoulin Pélissier, Mathieu Robain, Suzette Delaloge, Carine Bellera
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Overall survival (OS) is the gold standard endpoint to assess treatment efficacy in cancer clinical trials. In metastatic breast cancer (mBC), progression-free survival (PFS) is commonly used as an intermediate endpoint. Evidence
Externí odkaz:
https://doaj.org/article/95e587a2739d4813945eb54f7074bcab
Autor:
Hui Chen, Laurence Zitvogel, Guido Kroemer, Lisa Derosa, Suzette Delaloge, Olivier Caron, Sylvere Durand, Damien Drubay, Marine Fidelle, Carolina Alves Costa Silva, Aymeric Silvin, David Boulate, Olaf Mercier, Deborah Suissa, Roxanne Birebent, Tarek Ben-Ahmed, Anne-Laure Mallard de la Varende, Quentin Blampey, Charles-Antoine Dutertre, Aline Renneville
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/58b2b9285fa74ae8adfc9f3c8ef3808d
Autor:
Voichita Suciu, Carolla El Chamieh, Ranya Soufan, Marie-Christine Mathieu, Corinne Balleyguier, Suzette Delaloge, Zsofia Balogh, Jean-Yves Scoazec, Sylvie Chevret, Philippe Vielh
Publikováno v:
Cancers, Vol 15, Iss 20, p 4967 (2023)
Fine-needle aspiration (FNA) cytology has been widely used for the diagnosis of breast cancer lesions with the objective of differentiating benign from malignant masses. However, the occurrence of unsatisfactory samples and false-negative rates remai
Externí odkaz:
https://doaj.org/article/d79e03b726ff4b4ab72ae4a49f8f1f3a
Autor:
Alexandra Roux, Rachel Cholerton, Jonathan Sicsic, Nora Moumjid, David P. French, Paolo Giorgi Rossi, Corinne Balleyguier, Michal Guindy, Fiona J. Gilbert, Jean-Benoit Burrion, Xavier Castells, David Ritchie, Debbie Keatley, Camille Baron, Suzette Delaloge, Sandrine de Montgolfier
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background The MyPeBS study is an ongoing randomised controlled trial testing whether a risk-stratified breast cancer screening strategy is non-inferior, or eventually superior, to standard age-based screening at reducing incidence of stage
Externí odkaz:
https://doaj.org/article/31cebc25faf94567b9915d693125b04a
Autor:
Mylène Annonay, MD, Lisa Gauquelin, MD, Romain Geiss, MD, Mony Ung, MD, Laurence Cristol-Dalstein, MD, Marie-Ange Mouret-Reynier, MD PHD, Anthony Goncalves, MD PHD, Sophie Abadie-Lacourtoisie, MD, Eric Francois, MD, Christophe Perrin, MD, Johan Le Fel, MD, Véronique Lorgis, MD, Véronique Servent, MD, Lionel Uwer, MD, Christelle Jouannaud, MD, Marianne Leheurteur, MD, Florence Joly, MD PHD, Loic Campion, MD, Coralie Courtinard, MPH, Olivier Villacroux, MD, Thierry Petit, MD PHD, Pierre Soubeyran, MD, Catherine Terret, MD, Carine Bellera, PHD, Etienne Brain, MD PHD, Suzette Delaloge, MD MPH
Publikováno v:
Breast, Vol 60, Iss , Pp 138-146 (2021)
Background: Treatment and outcomes of patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have dramatically improved over the past 20 years. This work evaluated treatment patterns and outcomes according to age. Methods: Women who initi
Externí odkaz:
https://doaj.org/article/ade3e6c3b78e4adab88c10f438f12991
Autor:
Paolo Giorgi Rossi, Olivera Djuric, Valerie Hélin, Susan Astley, Paola Mantellini, Andrea Nitrosi, Elaine F. Harkness, Emilien Gauthier, Donella Puliti, Corinne Balleyguier, Camille Baron, Fiona J. Gilbert, André Grivegnée, Pierpaolo Pattacini, Stefan Michiels, Suzette Delaloge
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract We compared accuracy for breast cancer (BC) risk stratification of a new fully automated system (DenSeeMammo—DSM) for breast density (BD) assessment to a non-inferiority threshold based on radiologists’ visual assessment. Pooled analysis
Externí odkaz:
https://doaj.org/article/2ae46de7556848ca9eefd8ac6c0d1149
Autor:
Thomas Grinda, Natacha Joyon, Amélie Lusque, Sarah Lefèvre, Laurent Arnould, Frédérique Penault-Llorca, Gaëtan Macgrogan, Isabelle Treilleux, Anne Vincent-Salomon, Juliette Haudebourg, Aurélie Maran-Gonzalez, Emmanuelle Charafe-Jauffret, Coralie Courtinard, Camille Franchet, Véronique Verriele, Etienne Brain, Patrick Tas, Cécile Blanc-Fournier, Agnès Leroux, Delphine Loussouarn, Anca Berghian, Eva Brabencova, Jean Pierre Ghnassia, Jean-Yves Scoazec, Suzette Delaloge, Thomas Filleron, Magali Lacroix-Triki
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Expression of hormone receptor (HR) for estrogens (ER) and progesterone (PR) and HER2 remains the cornerstone to define the therapeutic strategy for breast cancer patients. We aimed to compare phenotypic profiles between matched primary and
Externí odkaz:
https://doaj.org/article/f5c605ed13024aff8ffd60be2690e7ab